TPP1 and late infantile neuronal ceroid lipofuscinosis: Specific polyclonal antibodies against TPP1 detect the absence or marked reduction of this protein in lymphocytes, lymphoblasts, fibroblasts [47] and brain homogenates [48] from LINCL patients, a technique found to be accurate, cost-effective, and rapid.